u 78517f has been researched along with Injury, Myocardial Reperfusion in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, CH; Lai, LN; Lei, JW; Song, LH; Song, XL; Zhang, XJ; Zhang, XY | 1 |
Hartman, JC; Linseman, DA; Wall, TM | 1 |
Altavilla, D; Avenoso, A; Campo, GM; Campo, S; Caputi, AP; Ferlito, M; Squadrito, F; Squadrito, G | 1 |
3 other study(ies) available for u 78517f and Injury, Myocardial Reperfusion
Article | Year |
---|---|
Lazaroid U83836E protects the heart against ischemia reperfusion injury via inhibition of oxidative stress and activation of PKC.
Topics: Animals; Cell Membrane; Chromans; Cytoplasm; Enzyme Activation; Male; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Piperazines; Protein Kinase C-epsilon; Protein Transport; Rats; Rats, Sprague-Dawley; Signal Transduction | 2016 |
The trolox analog, U-78517F, attenuates hypoxic injury in isolated cardiac myocytes.
Topics: Animals; Animals, Newborn; Antioxidants; Cell Hypoxia; Chromans; Creatine Kinase; Heart; In Vitro Techniques; L-Lactate Dehydrogenase; Myocardial Reperfusion Injury; Piperazines; Rats; Rats, Sprague-Dawley; Sarcolemma; Sulfhydryl Compounds | 1994 |
Antioxidant activity of U-83836E, a second generation lazaroid, during myocardial ischemia/reperfusion injury.
Topics: Aldehydes; Animals; Antioxidants; Cardiovascular System; Chromans; Free Radical Scavengers; Hydroxyl Radical; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Pancreatic Elastase; Piperazines; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Vitamin E | 1997 |